These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 23713424)
41. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer. Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820 [TBL] [Abstract][Full Text] [Related]
42. Targeted Nanoparticles Based on Alendronate Polyethylene Glycol Conjugated Chitosan for the Delivery of siRNA and Curcumin for Bone Metastasized Breast Cancer Applications. Mushtaq A; Li L; Grøndahl L; A A Macromol Biosci; 2024 Feb; 24(2):e2300268. PubMed ID: 37794635 [TBL] [Abstract][Full Text] [Related]
43. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
44. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928 [TBL] [Abstract][Full Text] [Related]
45. Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan. Seo DH; Jeong YI; Kim DG; Jang MJ; Jang MK; Nah JW Colloids Surf B Biointerfaces; 2009 Mar; 69(2):157-63. PubMed ID: 19135342 [TBL] [Abstract][Full Text] [Related]
46. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
47. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery. Pawar H; Douroumis D; Boateng JS Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474 [TBL] [Abstract][Full Text] [Related]
48. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa]. Wang JT; Lin DH; Qin LF; Wen Z; Guo GP Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701 [TBL] [Abstract][Full Text] [Related]
49. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901 [TBL] [Abstract][Full Text] [Related]
50. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite. Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139 [TBL] [Abstract][Full Text] [Related]
52. Thermo-sensitive nanoparticles for triggered release of siRNA. Yang Z; Cheng Q; Jiang Q; Deng L; Liang Z; Dong A J Biomater Sci Polym Ed; 2015; 26(4):264-76. PubMed ID: 25566877 [TBL] [Abstract][Full Text] [Related]
53. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug. Jang MK; Jeong YI; Nah JW Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624 [TBL] [Abstract][Full Text] [Related]
54. Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro. Yang X; Zhang Q; Wang Y; Chen H; Zhang H; Gao F; Liu L Colloids Surf B Biointerfaces; 2008 Feb; 61(2):125-31. PubMed ID: 17869489 [TBL] [Abstract][Full Text] [Related]
55. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
56. Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles. Kouchakzadeh H; Shojaosadati SA; Tahmasebi F; Shokri F Int J Pharm; 2013 Apr; 447(1-2):62-9. PubMed ID: 23454849 [TBL] [Abstract][Full Text] [Related]
57. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages. Zhang J; Tang C; Yin C Biomaterials; 2013 May; 34(14):3667-77. PubMed ID: 23419643 [TBL] [Abstract][Full Text] [Related]
58. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607 [TBL] [Abstract][Full Text] [Related]
59. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation. Shah M; Ullah N; Choi MH; Kim MO; Yoon SC Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562 [TBL] [Abstract][Full Text] [Related]
60. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery. Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]